Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShare-based Compensation (IS)Share-based Compensation (IS)Shares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Curaleaf Holdings (CURLF) EBT (2019 - 2026)

Curaleaf Holdings has reported EBT over the past 8 years, most recently at -$28.6 million for Q1 2026.

  • For Q1 2026, EBT fell 74.57% year-over-year to -$28.6 million; the TTM value through Mar 2026 reached -$43.4 billion, down 36585.1%, while the annual FY2025 figure was -$78.2 million, 31.0% up from the prior year.
  • EBT for Q1 2026 was -$28.6 million at Curaleaf Holdings, up from -$24.1 billion in the prior quarter.
  • Over five years, EBT peaked at $31.9 million in Q2 2022 and troughed at -$60.6 billion in Q4 2023.
  • A 5-year average of -$6.1 billion and a median of -$24.3 million in 2025 define the central range for EBT.
  • Biggest five-year swings in EBT: soared 149.53% in 2022 and later tumbled 111897.44% in 2025.
  • Year by year, EBT stood at -$249.2 million in 2022, then plummeted by 24226.2% to -$60.6 billion in 2023, then surged by 99.88% to -$73.0 million in 2024, then crashed by 32967.43% to -$24.1 billion in 2025, then soared by 99.88% to -$28.6 million in 2026.
  • Business Quant data shows EBT for CURLF at -$28.6 million in Q1 2026, -$24.1 billion in Q4 2025, and -$24.3 million in Q3 2025.